Navigation Links
Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
Date:12/9/2008

GREAT NECK, N.Y., Dec. 9 /PRNewswire/ --Scarguard Labs, LLC, a closely held company specializing in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced it has agreements in place with Publix Supermarkets and McKesson Drugs to carry Scarguard products.

"These are very positive developments for Scarguard," said CEO Joel Studin. "McKesson is the largest drug wholesaler in the U.S., with more than 20 distribution centers across the country. Publix is the fourth largest grocery store chain in the U.S., and caters to a high-end clientele through its 450 stores across the Southeast.

"The McKesson agreement complements our existing agreements with Amerisource Bergen and Cardinal Health, and means that we have agreements with the three largest pharmaceutical distributors. This will give our products enormous visibility to retail customers across the country and with large independent drugstores chains in particular. The agreement immediately placed our products in McKesson's two largest retailers, and as a result, we have seen at least a 15% increase in the dollar volume of our sales.

"The Publix clientele is precisely the target market for Scarguard products," continued Studin. "It has been a long time goal of ours to reach an agreement with them. Eventually Publix came to believe that our products are the most efficacious of the category and saw our successes in other food chains such as ShopRite and Pathmark. We consider this agreement to be a highlight of our strategy to increase the retail presence for our products by expanding our presence in other channels."

About Scarguard Labs, LLC

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development For more information, please visit our website at www.scarguard.com.

    Company Contact:                                  Investor Relations:
    Richard E. Pino                                   John McNamara
    Chief Financial Officer/Investor Relations        Cameron Associates
    Scarguard Labs, LLC                               (212) 245-8800 Ext. 205
    516-482-8050                                      john@cameronassoc.com
    Richard@scarguard.com 


'/>"/>
SOURCE Scarguard Labs, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
2. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
3. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
4. Rohm and Haas Expands in India
5. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
6. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
7. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
8. Specialty Blades, Inc. Expands Management Team With New VP Engineering
9. CRH Medical expands Las Vegas operations
10. US Med-Equip Expands Corporate Support Center
11. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... ... Florida Hospital presents Heart Health Awareness night on Sunday February 14th, as ... The puck drops at 6:00pm, but fans will have the opportunity to experience the ... The MEGA Heart will be located on Ford Thunder Alley and provide fans with ...
(Date:2/11/2016)... ... February 11, 2016 , ... The president released a FY 2017 ... but would shift more of the cost burden to military beneficiaries. , MOAA’s ... in the defense budget as including limited quantifiable benefit fixes mixed with numerous beneficiary ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... discuss how to improve care by making data on heart procedures public and ... Summit on Transparency and Public Reporting of Pediatric and Congenital Heart Disease Outcomes ...
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, ... Benefit Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. ... with Intel on value-based health benefits program Connected Care, will discuss the challenges ...
(Date:2/11/2016)... ... 11, 2016 , ... "What holds you back from ... a question as a challenge for his readers to examine the full scale ... (published by Partridge Singapore), Clarke explores the subject with more depth, revealing time-honored ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , February 11, 2016 --> ... of a new research report, titled "Sports Medicine Devices Market ... 2013 - 2019". According to the report, the global sports ... CAGR from 2013 to 2019, growing from a value of ... --> --> The global sports ...
(Date:2/11/2016)... , February 11, 2016 Jeffrey ... Worldwide Clinical Trials, will present at this year,s Summit for ... Hyatt Regency in Miami, FL. Zucker ... to optimize study execution, supporting SCOPE,s "Improving Site Study Activation ... place on Thursday, Feb. 25 at 11:05 a.m. ...
(Date:2/11/2016)... F ast access ... at the point of need ... medical information products and services, has launched a ClinicalKey mobile ... a mobile device. Elsevier designed the mobile app to allow users to ... available in Android and iOS formats for mobile ...
Breaking Medicine Technology: